Review





Similar Products

95
MedChemExpress volasertib
( A-B ) Percent relative cell viability and ( C-D ) IC50 values of MPNST cell lines after 5 days of treatment with either PLK1 inhibitors <t>volasertib</t> or BI-2536 ( A & C ) or EGFR inhibitors erlotinib or osimertinib ( B & D ).
Volasertib, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/volasertib/product/MedChemExpress
Average 95 stars, based on 1 article reviews
volasertib - by Bioz Stars, 2026-02
95/100 stars
  Buy from Supplier

95
MedChemExpress erlotinib
( A-B ) Percent relative cell viability and ( C-D ) IC50 values of MPNST cell lines after 5 days of treatment with either PLK1 inhibitors <t>volasertib</t> or BI-2536 ( A & C ) or EGFR inhibitors erlotinib or osimertinib ( B & D ).
Erlotinib, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/erlotinib/product/MedChemExpress
Average 95 stars, based on 1 article reviews
erlotinib - by Bioz Stars, 2026-02
95/100 stars
  Buy from Supplier

93
MedChemExpress erlotinib hydrochloride
( A-B ) Percent relative cell viability and ( C-D ) IC50 values of MPNST cell lines after 5 days of treatment with either PLK1 inhibitors <t>volasertib</t> or BI-2536 ( A & C ) or EGFR inhibitors erlotinib or osimertinib ( B & D ).
Erlotinib Hydrochloride, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/erlotinib hydrochloride/product/MedChemExpress
Average 93 stars, based on 1 article reviews
erlotinib hydrochloride - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier

Image Search Results


( A-B ) Percent relative cell viability and ( C-D ) IC50 values of MPNST cell lines after 5 days of treatment with either PLK1 inhibitors volasertib or BI-2536 ( A & C ) or EGFR inhibitors erlotinib or osimertinib ( B & D ).

Journal: bioRxiv

Article Title: Multi-omics integration of malignant peripheral nerve sheath tumors identifies potential targets based on chromosome 8q status

doi: 10.64898/2026.01.26.701599

Figure Lengend Snippet: ( A-B ) Percent relative cell viability and ( C-D ) IC50 values of MPNST cell lines after 5 days of treatment with either PLK1 inhibitors volasertib or BI-2536 ( A & C ) or EGFR inhibitors erlotinib or osimertinib ( B & D ).

Article Snippet: Erlotinib, osimertinib, and volasertib were purchased from MedChemExpress (Monmouth Junction, NJ, USA).

Techniques: